Closed transaction
- Advised by
- Deal stage
- Closed transaction
- Service
- Equity
- Sector
- Healthcare
- Sub-sector
- Other Healthcare
- Market
- Asia
- Contact
- garry.hersey@afgventuregroup.com
Deal details
Client has global licence for commercialisation of technology that provides a precise, reliable and cost-effective real-time measurement of medical radiation skin doses and dose rates, in the application of radiotherapy for cancer,angiography and diagnostic/interventional radiology which typically use high levels of radiation.
Post clinical trials and pre-revenue. Distribution agreements being put in place and mass production finalised.
Deal team
01Members / select to view profile
Garry Hersey
RoleManaging Partner - ASEAN
FirmAFG Venture Group
ASEAN focus: foreign direct investment into Vietnam, transaction advisory and funding with emphasis on steel, financial services and building materials.
View profile
AFG Venture Group latest deals
Equity advisory
Setmetrics provides engineering grade modelling tool to allow commercial and industrial built environment owners to improve facility and energy management efficiency.
- Adviser
- AFG Venture Group
- Where
- Australia
- Year
- 2023
Equity advisory
Raise Pre IPO $1.2 Million capital for a sustainable Electric Vehicle Charging Stations company, which is aggregating carwash business and adding rapid charging capacity.
- Adviser
- AFG Venture Group
- Where
- Australia
- Year
- 2023
Equity advisory
Raise AUD $1Million: AI coaching for professional & personal development platform for individuals & teams.
- Adviser
- AFG Venture Group
- Where
- Australia
- Year
- 2023
Equity advisory
Raising convertible notes $10Million to restart an Australian Gold Mine.
- Adviser
- AFG Venture Group
- Where
- Australia
- Year
- 2023
More deals in Healthcare
Sell-side advisory
NUTRIBRAIN was sold to LABORATORIOS RUBIÓ.
- Adviser
- INEO Corporate
- Where
- Spain
- Year
- 2026
Sell-side advisory
PharmaX Solutions was sold to BioPhorum.
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2026
Sell-side advisory
Nostos Genomics was sold to Limbus Medical Technologies (varvis®).
- Adviser
- Hoffmann & Partner
- Where
- Switzerland
- Year
- 2025
Sell-side advisory
3iM Healthcare AB acquired Avia Pharma.
- Adviser
- Evli Corporate Finance AB
- Where
- Finland
- Year
- 2025
Membership
Gain worldwide reach with CapFive M&A professionals
The professionals of CapFive have been carefully selected on the basis of reputation, relationships, proven track record and knowledge of local markets.
Become a member